Q83I20 AF NFT

1-deoxy-D-xylulose-5-phosphate synthase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeiegsempdfkifizc2qb7tatpvr3seg4bq6zwoakkokggvdha3srdvy/metadata.json
IPFS of structure file: 
bafybeihadxf36qqz7o5ufj7ws5n3fxm6f36ig46yocsflsmi6h3jk3axzy/AF-Q83I20-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x60b588AdB9eC3Ae190f6dfe62fBd8F2eb45726FD
First NFT owner address (bech32): 
genesis1vz6c3tdeasawry8kmlnzl0v09669wfha0l0tvz
Current NFT ID #108548 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
108548
Accession (UniProt):
Q83I20
Name::
1-deoxy-D-xylulose-5-phosphate synthase
Experimental Method:
Predicted structure
Sequence source:
Tropheryma whipplei (strain TW08/27)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q83I20 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q83I20|DXS_TROW8 1-deoxy-D-xylulose-5-phosphate synthase OS=Tropheryma whipplei (strain TW08/27) OX=218496 GN=dxs PE=3 SV=1 MCTKRQYGLLESIRSPRDLDSFTPHQLDELECQVRDFLIQSVAKTGGHLGSNLGVVELSIALHRSFRSPEDCIIFDVGHQCYVHKLITGRHDFKALRCKNGLSGYPSRHESNHDIVENSHASAALSWADGVSRARTLLGNDNYVIAVVGDGSLTGGMCWEALNNISDDNNRRLVIVVNDNGRSYARTIGGIARFLNAVRASKSYLWLRESSEAVFSHMGSPGRRLYQGIRGAIHGFLSRFSSSNKLFSNLDIRYLGPINGHNRKALEKAFKQAKQYARPIIVHVITEKGHGYPPALEDALDCLHTVGVIDPSTGKSASVQGQVRQDTWTGVFGEELLRLAESNTNIVAVTAAMLHPTGLSMFAEKFPHRVFDVGIAEQHAVASAAGLAYEGLHPVVAIYSTFMNRAFDQVMMDVALHGAPVTFVLDRAGITGPDGASHHGIWDLSLLRIVPGIKLYAPRDASTLRNTLALVCSEDCPTAIRFPRGSVCDDLPALRSLDDGIDVLYGSCDREDIVIVAIGVMAHACVRAAQLLAESGIESTVINPVCFWPLHRQVLARVSKAKLVVLAEEGAKSPGLGDYIAGRRLLEFVIPGDFQPQGSRDELLDAIGLNGEHIARKIKARFNQIINCV